| 中文同義詞: | 奧希類似物;AST2818甲磺酸鹽;N-[2-[[2-(二甲基氨基)乙基]甲基氨基]-5-[[4-(1-甲基-1H-吲哚-3-基)-2-嘧啶基]氨基]-6-(2,2,(2-三氟乙氧基)-3-吡啶基]-2-丙烯酰胺甲磺酸鹽;化合物AST2818 MESYLATE;甲磺酸伏美替尼;N-(2-((2-(二甲基氨基)乙基)(甲基)氨基)-5-((4-(1-甲基-1H-吲哚-3-基)嘧啶-2-基)氨基)-6-(2,2,2-三氟乙氧基)吡啶-3-基)丙烯酰胺甲磺酸鹽;甲磺酸阿氟替尼(AST2818);羅恩 N-(2-((2-(二甲基氨基)乙基)(甲基)氨基)-5-((4-(1-甲基-1H-吲哚-3-基)嘧啶-2-基)氨基)-6-(2,2,2-三氟乙氧基)吡啶-3-基)丙烯酰胺甲磺酸鹽 R070057-25mg |
| 英文同義詞: | N-[2-[[2-(Dimethylamino)ethyl]methylamino]-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]-6-(2,2,2-trifluoroethoxy)-3-pyridinyl]-2-propenamide compd. with methanesulfonate (1:1);AST2818 mesylate;Alflutinib mesylate (AST2818);Alflutinib methanesulfonate;Alflutinib (AST2818 mesylate);Alflutinib mesylate (Furmonertinib);cancer,Epidermal growth factor receptor,AST2818,esistant mutation,Alflutinib,Alflutinib mesylate,AST-2818,Furmonertinib,HER1,AST 2818,NSCLC,ErbB-1,Inhibitor,EGFR,T790M,inhibit;N-(2-((2-(Dimethylamino)ethyl)(methyl)amino)-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)acrylamide methanesulfonate |